Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Elizabeth Geerling Clear advanced filters

  • The US National Institute of Allergy and Infectious Diseases and Foundation for the National Institutes of Health convened a 2-day workshop announcing four agents to enter RECOVER–Treating Long COVID clinical trials and obtained input on future directions.

    • Robert W. Eisinger
    • Joseph J. Breen
    • Jeffery K. Taubenberger
    News & Views
    Nature Immunology
    Volume: 26, P: 2126-2129

  • The US National Institute of Allergy and Infectious Diseases (NIAID) and the Foundation for the National Institutes of Health (FNIH) held a three-day workshop to assess the landscape of long COVID clinical studies and develop plans for the RECOVER-TLC clinical trials program.

    • Joseph J. Breen
    • Robert W. Eisinger
    • Jeanne M. Marrazzo
    News & Views
    Nature Immunology
    Volume: 26, P: 536-539